Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Oncogene ; 26(1): 30-41, 2007 Jan 04.
Article in English | MEDLINE | ID: mdl-16799633

ABSTRACT

MUC4 mucin is a high molecular weight transmembrane glycoprotein that plays important roles in tumour biology. It is aberrantly expressed in pancreatic adenocarcinoma, while not being detectable in the normal pancreas. Previous studies have demonstrated that the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel that is defective in CF, is implicated in multiple cellular functions, including gene regulation. In the present study, using a CFTR-defective pancreatic cancer cell line and its derived subline expressing functional CFTR, we report that MUC4 expression is negatively regulated by CFTR. Short-interfering RNA (siRNA)-mediated silencing of CFTR also leads to an increased expression of MUC4. Additionally, our results suggest that CFTR-mediated regulation of MUC4 is cell density-dependent and is achieved by transcriptional and posttranslational mechanisms. Moreover, in a panel of pancreatic cancer cell lines and normal pancreas, we observed that CFTR was downregulated in pancreatic cancer cells and negatively correlated with MUC4 in most cases. An aberrant expression of MUC4 was also detected in the CF pancreas. Downregulation of CFTR in pancreatic adenocarcinoma and its inverse association with the tumour-linked mucin, MUC4, indicate novel function(s) of CFTR in pancreatic tumour biology and suggest the implication of new signalling pathway(s) in MUC4 regulation.


Subject(s)
Adenocarcinoma/metabolism , Cystic Fibrosis Transmembrane Conductance Regulator/physiology , Mucins/genetics , Pancreatic Neoplasms/metabolism , Protein Processing, Post-Translational , Adenocarcinoma/pathology , Base Sequence , Blotting, Northern , Cell Line, Tumor , DNA Primers , Humans , Mucin-4 , Pancreatic Neoplasms/pathology , Promoter Regions, Genetic , RNA, Messenger/genetics , RNA, Small Interfering , Reverse Transcriptase Polymerase Chain Reaction
2.
Oncogene ; 26(51): 7251-61, 2007 Nov 08.
Article in English | MEDLINE | ID: mdl-17525742

ABSTRACT

MUC4 is a transmembrane mucin, which is aberrantly expressed in pancreatic adenocarcinoma with no detectable expression in the normal pancreas. Here, we present a novel mechanism of IFN-gamma-induced expression of MUC4 in pancreatic cancer cells. Our studies highlight the upregulation of STAT-1 as a basis for MUC4 induction and demonstrate that its activation and upregulation by IFN-gamma are two distinct, albeit temporally integrated, signalling events that drive the selective induction of IRF-1 and MUC4, respectively, within a single cell system. The profile of interferon regulatory factor (IRF)-1 gene induction by IFN-gamma is consistent with its rapid transactivation by phospho-Y701-STAT-1. In contrast, the induction of the MUC4 mucin gene expression is relatively delayed, and occurs only in response to an increase in STAT-1 expression. A progressive binding of STAT-1 to various gamma-interferon-activated sequences (GAS) in the MUC4 promoter is observed in chromatin immunoprecipitation assay, indicating its direct association. Stimulation of STAT-1 expression by double-stranded polynucleotides or ectopic expression is shown to induce MUC4 expression, without Y701 phosphorylation of STAT-1. This effect is abrogated by short interfering RNA (siRNA)-mediated inhibition of STAT-1 expression, supporting further the relevance of STAT-1 in MUC4 regulation. In conclusion, our findings identify a novel mechanism for MUC4 regulation in pancreatic cancer cells and unfold new perspectives on the foundation of IFN-gamma-dependent gene regulation.


Subject(s)
Gene Expression Regulation/drug effects , Interferon-gamma/pharmacology , Mucins/genetics , Pancreatic Neoplasms/metabolism , STAT1 Transcription Factor/physiology , Up-Regulation , Base Sequence , Cell Line, Tumor , Humans , Mucin-4 , Mucins/biosynthesis , Pancreatic Neoplasms/pathology , Phosphorylation , Promoter Regions, Genetic , RNA Interference , RNA, Small Interfering , Reverse Transcriptase Polymerase Chain Reaction , Transcriptional Activation
3.
Clin Cancer Res ; 7(12): 4033-40, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11751498

ABSTRACT

PURPOSE: Mucins are important biomolecules that frequently display an altered expression under pathological conditions. In a search for a unique and reliable marker(s) specific for pancreatic adenocarcinoma, we investigated the expression of different MUC genes in pancreatic tumors and tumor cell lines, in chronic pancreatitis, and in the normal pancreas. EXPERIMENTAL DESIGN: Total RNA from 16 pancreatic tumors, 10 chronic pancreatitis tissues, 7 normal pancreas tissues, and 15 pancreatic tumor cell lines were analyzed by reverse transcription-PCR with primers specific for MUC1, MUC2, MUC3, MUC4, MUC5AC, MUC5B, MUC6, and MUC7 genes and by RNA slot blot analyses. RESULTS: Our results revealed that of all of the mucins examined, only MUC4 displayed a differential expression that was specific for pancreatic adenocarcinoma. Indeed, a substantial number of tumor tissue samples (12 of 16) and tumor cell lines (11 of 15) expressed MUC4 mRNA, whereas samples from chronic pancreatitis (0 of 10) and the normal pancreas (0 of 7) tissues failed to exhibit any detectable level of this mucin. In contrast, no significant alteration was observed in the expression of the other mucins relative to that in the normal pancreas samples. CONCLUSIONS: Overall, this work demonstrates that pancreatic mucin MUC4 is a tumor-associated mucin. Furthermore, the present study introduces a novel avenue to discriminate between pancreatic adenocarcinoma and pancreatitis. Future investigations of the role played by MUC4 in pancreatic adenocarcinoma may prove to be useful in the formulation of strategies for the diagnosis and therapeutic treatment of this malignancy.


Subject(s)
Adenocarcinoma/genetics , Biomarkers, Tumor/analysis , Gene Expression Regulation, Neoplastic , Mucins/genetics , Pancreatic Neoplasms/genetics , Pancreatitis/genetics , Aged , Aged, 80 and over , Chronic Disease , Female , Gene Expression Regulation , Humans , Male , Middle Aged , Mucin-4 , Mucins/analysis , Pancreas/chemistry , RNA/genetics , RNA/isolation & purification , RNA, Neoplasm/genetics , RNA, Neoplasm/isolation & purification , Reference Values , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured
4.
Phytopathology ; 87(9): 892-8, 1997 Sep.
Article in English | MEDLINE | ID: mdl-18945059

ABSTRACT

ABSTRACT Phloem-dependent movement of pepper mottle potyvirus (PepMoV) through Capsicum annuum occurs in a defined pattern through the stem and into uninoculated leaves. The route of movement of PepMoV through the stem of C. annuum 'Early Calwonder' was tracked using immunotissue blot analysis and immunomicroscopy. Virus was shown to move from the inoculated leaf down the stem toward the roots via the external phloem. At some location between the cotyledonary node and the roots, PepMoV entered the internal phloem through which it rapidly spread upward the length of the stem to the young tissues. Translocation of PepMoV through the stem occurred in an asymmetric fashion, i.e., virus remained on the side of the stem to which the inoculated leaf was attached as it translocated the length of the stem. Spread and accumulation of PepMoV into uninoculated leaves appeared to occur in a source-to-sink pattern similar to that described for the flow of photoassimilates and similar to other virus and viroid-host systems.

5.
Br J Cancer ; 91(9): 1633-8, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15494719

ABSTRACT

Mucins are members of an expanding family of large multifunctional glycoproteins. Pancreatic mucins have important biological functions, including the protection, lubrication, and moisturisation of the surfaces of epithelial tissues lining ductal structures within the pancreas. Several lines of evidence support the notion that deregulated mucin production is a hallmark of inflammatory and neoplastic disorders of the pancreas. Herein, we discuss the factors that contribute to the lethality of pancreatic cancer as well as the key role played by mucins, particularly MUC1 and MUC4, in the development and progression of the disease. Aspects pertaining to the aberrant expression and glycosylation of mucins are discussed, with special emphasis on their potential impact on the design and implementation of adequate diagnostic and therapeutic strategies for combating this lethal malignancy.


Subject(s)
Mucin-1/physiology , Mucins/physiology , Pancreatic Neoplasms/metabolism , Glycosylation , Humans , Mucin-4 , Pancreatic Neoplasms/therapy
SELECTION OF CITATIONS
SEARCH DETAIL